SCHEMBL22278760

SCHEMBL22278760

CC(CCN1CCN(S(=O)(=O)c2cccc(C(F)(F)F)c2)c2cc(Br)ccc21)OCCC(=O)OC(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ RORC P51449 20/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22278486 0.93 RORC (0.43) RORC
SCHEMBL24061139 0.86 RORC (0.44) RORC
SCHEMBL22278745 0.86 RORC (0.43) RORC
SCHEMBL22278720 0.84 RORC (0.56) RORC
SCHEMBL22278483 0.84 RORC (0.43) RORC
SCHEMBL22278706 0.84 RORC (0.41) RORC
SCHEMBL22278490 0.83 RORC (0.47) RORC
SCHEMBL22278511 0.82 HPGD (0.49) RORC
SCHEMBL22278690 0.82 RORC (0.47) RORC
SCHEMBL22278716 0.82 RORC (0.46) RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3915977-A1 1,2,3,4-TETRAHYDROQUINOXALINE DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Abbisko Therapeutics Co., Ltd. (CN) 2021-12-01 — — EP disclosed
WO-2020151232-A1 1,2,3,4-TETRAHYDROQUINOXALINE DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 上海和誉生物医药科技有限公司 2020-07-30 — — WO disclosed
Send feedback